Clinical Trial

Prevalence of NAFLD in T2DM Patients

Name: Prevalence of NAFLD in T2DM Patients — clinical trial record (NCT06445335)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PAD2ZOL

Active, Not Recruiting

View on ClinicalTrials.gov →

Summary

To determine the prevalence of non-alcoholic fatty liver disease (NAFLD) in patients with type 2 diabetes mellitus (T2DM).

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2024-06-03; most recent amendment 2025-11-24.

Trial Details

NCT Number	NCT06445335
Lead Sponsor	Ziekenhuis Oost-Limburg
Conditions	NAFLD, T2D, Type 2 Diabetes, Fatty Liver, Nonalcoholic
Enrollment	385 participants
Start Date	2019-03-01
Primary Completion	2026-11-01 (estimated)
Study Completion	2026-11-01 (estimated)
Updated on ClinicalTrials.gov	2025-12-02